Valuations of Early-Stage Companies and Disruptive Technologies: How to Value Life Science, Cybersecurity and ICT Start-ups, and their Technologies

Part II Overcoming Valuation Hurdles: How to Conduct Valuations Under Unique Circumstances
3 Understanding the Basic Elements of Stockholder Statements and Their Use in Valuations
4 Valuation Methods: The First Chicago Venture Method and the Use of Real Options

Part III Behavioral Factors: How Psychology Affects Bias in Valuations
5 Introduction to Behavioral Finance​ 6 An Overview of Investor Behavior in Financial Markets and Psychological Influences on Valuations7 How to Overcome Investor Behavior and Psychological Influences in Valuations: How to Evaluate a Dream?

Part IV An Introduction to Valuations in R&D- Intensive Industries
8 The Pharmaceutical Sector
9 Life Sciences: Disrupting Biologic Drugs Manufacturing
10 An Overview of the Cybersecurity and the Renewable Energy Sectors

Part V Actual Valuations
11 Company A: Pharmaceutical/New Compounds
12 Company B: Pharmaceutical/Biologics
13 Company C: Cybersecurity14 Company D: Renewable Energy
15 Conclusion

Appendix A: Capitalization Rate for Renewable Energy Firms
Appendix B: Capitalization Rate for Software Firms
Index